AKT1 and central nervous system cancer: Solinas et al. investigated CBD in U87-MG and T98G glioma cell lines and reported inhibition of cell proliferation and invasiveness, a downregulation of ERK and Akt signalling and a decrease in the hypoxia-inducible factor HIF-1α expression (Solinas et al. 2013).